价格

prourokinase

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Application of prourokinase and prourokinase mutant in acute myocardial infarction facilitated percutaneous coronary intervention (PCI)
CN 105148261 A申请人: SUZHOU LANDING BIOPHARMACEUTICAL CO LTD优先权: 2008
CN
US
4 件公开
C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
- US 2007298023 A1
  申请人: GUREWICH VICTOR优先权: 2007
  US
  4 件公开
- US 2009010916 A1
  申请人: GUREWICH VICTOR优先权: 2008
  US
Use of prourokinase and its variants against coagulopathy caused by viruses
US 11554163 B2申请人: LIU JIANNING优先权: 2020
CN
US
2 件公开
Prourokinase variant capable of being activated by urokinase or itself and coding gene, preparing method and use thereof
CN 1142278 C申请人: LIU JIANMING优先权: 2001
CN
2 件公开
Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery
US 7179461 B2申请人: UNIV JOHNS HOPKINS优先权: 2003
US
2 件公开
Urokinase zymogen mutant
CN 1277262 A申请人: LIU JIANNING优先权: 2000
CN
Trombolysis agent KGD - prourokinase chimaera, preparing process and application thereof
CN 1520882 A申请人: BIOENGINEERING INST ACADEMY OF优先权: 2003
CN
Recombination protein for dissolving thrombus and its engineering bacteria
CN 1534094 A申请人: UNIV ZHONGSHAN优先权: 2003
CN
Anti prourokinase monoclonal antibody hybrid oma cell line and its application
CN 1556204 A申请人: INST BIOENGINEERING ACADEMY MILITARY MEDICAL SCIENCES PLA优先权: 2004
CN
New use of gene reconstituted urokin as origin
CN 1651077 A申请人: TIANJIN TIANSHILI PHARMACEUTIC优先权: 2004
CN

药物

prourokinase

专利

C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis